296
Participants
Start Date
December 2, 2016
Primary Completion Date
December 27, 2017
Study Completion Date
December 27, 2017
SAR425899
Self-administered by SC injection using a solution for injection in cartridge.
Placebo
Self-administered by SC injection using a solution for injection in cartridge.
Liraglutide
Self-administered by SC injection using a pre-filled pen.
Metformin
Orally administered at a stable dose , \>=1500 mg daily stable dose or maximal tolerated dose.
Investigational Site Number 3480002, Budapest
Investigational Site Number 3480008, Budapest
Investigational Site Number 3480005, Budapest
Investigational Site Number 3480006, Budapest
Investigational Site Number 3480007, Budapest
Investigational Site Number 3480001, Balatonfüred
Investigational Site Number 8400022, New York
Investigational Site Number 2760003, Berlin
Investigational Site Number 7240001, A Coruña
Investigational Site Number 7240007, Ferrol
Investigational Site Number 2030002, Praha 9 - Klanovice
Investigational Site Number 8400019, Rockville
Investigational Site Number 7240002, Madrid
Investigational Site Number 7240003, Málaga
Investigational Site Number 7240004, Málaga
Investigational Site Number 8400025, Miami
Investigational Site Number 8400007, Palm Harbor
Investigational Site Number 7240006, Las Palmas de Gran Canaria
Investigational Site Number 8400028, Sheffield
Investigational Site Number 7240008, Seville
Investigational Site Number 4840004, Actopan
Investigational Site Number 4840001, Guadalajara
Investigational Site Number 4840003, Guadalajara
Investigational Site Number 8400003, Troy
Investigational Site Number 8400005, Fargo
Investigational Site Number 8400013, Chicago
Investigational Site Number 4840002, Monterrey
Investigational Site Number 8400016, Wichita
Investigational Site Number 8400023, Wichita
Investigational Site Number 8400018, New Orleans
Investigational Site Number 8400006, Dallas
Investigational Site Number 4840006, San Juan del Río
Investigational Site Number 8400021, Houston
Investigational Site Number 8400017, Sugar Land
Investigational Site Number 8400026, San Antonio
Investigational Site Number 8400004, Austin
Investigational Site Number 2030001, Krnov
Investigational Site Number 8400027, Denver
Investigational Site Number 8400024, Los Angeles
Investigational Site Number 8400001, Los Angeles
Investigational Site Number 8400002, Huntington Park
Investigational Site Number 8400012, Port Hueneme
Investigational Site Number 6430002, Saint Petersburg
Investigational Site Number 6430004, Saint Petersburg
Investigational Site Number 6430001, Saint Petersburg
Investigational Site Number 6430005, Voronezh
Investigational Site Number 6430003, Saratov
Investigational Site Number 8400014, Flint
Investigational Site Number 8400020, Linden
Investigational Site Number 1240008, Québec
Investigational Site Number 1240005, Sainte-Foy
Investigational Site Number 1240002, Sherbrooke
Investigational Site Number 1240001, Toronto
Investigational Site Number 1240003, Vancouver
Investigational Site Number 2030003, České Budějovice
Investigational Site Number 2030004, Praha 10 - Uhrineves
Investigational Site Number 2760001, Dresden
Investigational Site Number 2760006, Hohenmölsen
Investigational Site Number 7240005, Barcelona
Lead Sponsor
Sanofi
INDUSTRY